Huib N. Caron cancer researcher
Caron, H.N. (Hubertus Nicolaas)
Caron, H.N.
VIAF ID: 289502719 (Personal)
Permalink: http://viaf.org/viaf/289502719
Preferred Forms
-
100 1 _ ‡a Caron, H.N.
-
-
100 0 _ ‡a Huib N. Caron ‡c cancer researcher
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Behandelingsstrategieën bij kinderen met verdenking op kanker |
![]() |
Cancer predisposition in children : genetics, phenotypes & screening |
![]() |
Childhood cancer treatment optimization : in rhabdomyosarcoma and supportive care |
![]() |
Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity |
![]() |
Evaluation of a patient information website for childhood cancer survivors |
![]() |
Fenretinide induces mitochondrial ROS and inhibits the mitochondrial respiratory chain in neuroblastoma |
![]() |
The guardians' perspective on paediatric cancer treatment in Malawi and factors affecting adherence |
![]() |
High delta-like 1 expression in a subset of neuroblastoma cell lines corresponds to a differentiated chromaffin cell type |
![]() |
High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma |
![]() |
High efficacy of the BCL-2 inhibitor ABT199 (venetoclax) in BCL-2 high-expressing neuroblastoma cell lines and xenografts and rational for combination with MCL-1 inhibition |
![]() |
High Hospitalization Rates in Survivors of Childhood Cancer: A Longitudinal Follow-Up Study Using Medical Record Linkage |
![]() |
High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programs |
![]() |
High risk of symptomatic cardiac events in childhood cancer survivors |
![]() |
Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins. |
![]() |
Histone deacetylases (HDACs): characterization of the classical HDAC family |
![]() |
The human transcriptome map reveals extremes in gene density, intron length, GC content, and repeat pattern for domains of highly and weakly expressed genes |
![]() |
Identification of BIRC6 as a novel intervention target for neuroblastoma therapy |
![]() |
Inactivation of CDK2 is synthetically lethal to MYCN over-expressing cancer cells |
![]() |
The influence of patient reported outcomes on the discussion of psychosocial issues in children with cancer. |
![]() |
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features |
![]() |
Knockdown of survivin (BIRC5) causes apoptosis in neuroblastoma via mitotic catastrophe |
![]() |
LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. |
![]() |
Local Resection and Brachytherapy for Primary Orbital Rhabdomyosarcoma: Outcome and Failure Pattern Analysis |
![]() |
Malnutrition and neutropenia in children treated for Burkitt lymphoma in Malawi |
![]() |
Meta-analysis of neuroblastomas reveals a skewed ALK mutation spectrum in tumors with MYCN amplification |
![]() |
MIBG scintigraphy and PET imaging for diagnosing neuroblastoma |
![]() |
Minimal residual disease detection in autologous stem cell grafts from patients with high risk neuroblastoma. |
![]() |
Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children |
![]() |
Moleculaire kinderoncologie : "Van gen naar genezing" |
![]() |
Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression |
![]() |
MON-458 Radiological Alterations Of The Hypothalamic-pituitary Region After Craniospinal Irradiation For Medulloblastoma During Childhood |
![]() |
The N-myc and c-myc downstream pathways include the chromosome 17q genes nm23-H1 and nm23-H2. |
![]() |
Neuroblastoma: biology, prognosis, and treatment |
![]() ![]() |
Neuroblastoma messenger RNA is frequently detected in bone marrow at diagnosis of localised neuroblastoma patients |
![]() |
Newly-derived neuroblastoma cell lines propagated in serum-free media recapitulate the genotype and phenotype of primary neuroblastoma tumours |
![]() |
NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome |
![]() |
Obituary of a very special doctor, Dr Jan de Kraker (October 18, 1944 to January 19, 2012). |
![]() |
Peripheral stem cell apheresis is feasible post Iodine-metaiodobenzylguanidine- therapy in high-risk neuroblastoma, but results in delayed platelet reconstitution |
![]() |
The Phox2B homeobox gene is mutated in sporadic neuroblastomas |
![]() |
The polyamine metabolism genes ornithine decarboxylase and antizyme 2 predict aggressive behavior in neuroblastomas with and without MYCN amplification |
![]() |
Prevalence and patterns of morphological abnormalities in patients with childhood cancer |
![]() |
Prevalence of congenital heart defects in neuroblastoma patients: a cohort study and systematic review of literature. |
![]() |
Prevention of anthracycline-induced cardiotoxicity in children: the evidence |
![]() |
Prevention of central venous catheter-associated bloodstream infections in paediatric oncology patients using 70% ethanol locks: A randomised controlled multi-centre trial |
![]() |
Prognostic factors for progression of childhood optic pathway glioma: a systematic review |
![]() |
Promising effects of the 4HPR-BSO combination in neuroblastoma monolayers and spheroids |
![]() |
QOS-48PREVALENCE AND RISK FACTORS OF EARLY ENDOCRINE DISORDERS IN CHILDHOOD BRAIN TUMOR SURVIVORS: A NATIONWIDE MULTICENTER STUDY. |
![]() |
Rearrangements and increased expression of cyclin D1 (CCND1) in neuroblastoma |
![]() |
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations |
![]() |
Renal dysfunction and elevated blood pressure in long-term childhood cancer survivors |
![]() |
Reporting health-related quality of life scores to physicians during routine follow-up visits of pediatric oncology patients: is it effective? |
![]() |
Response to "cancer care in the pediatric surgical patient: a paradigm to abolish volume-outcome disparities in surgery". |
![]() |
Retinoic acid reduces the cytotoxicity of cyclopentenyl cytosine in neuroblastoma cells |
![]() |
Risk of Symptomatic Stroke After Radiation Therapy for Childhood Cancer: A Long-Term Follow-Up Cohort Analysis |
![]() |
The role of the 'innovative therapies for children with cancer' (ITCC) European consortium. |
![]() |
Sequencing of neuroblastoma identifies chromothripsis and defects in neuritogenesis genes |
![]() |
Should anthracyclines and dexrazoxane be used for children with cancer? |
![]() |
Social outcomes in adult survivors of childhood cancer compared to the general population: linkage of a cohort with population registers |
![]() |
Stability of PCR targets for monitoring minimal residual disease in neuroblastoma. |
![]() |
Studying Hospitalizations and Mortality in the Netherlands: Feasible and Valid Using Two-Step Medical Record Linkage with Nationwide Registers |
![]() |
Surveillance of hepatic late adverse effects in a large cohort of long-term survivors of childhood cancer: prevalence and risk factors |
![]() |
Synergistic interaction between cisplatin and gemcitabine in neuroblastoma cell lines and multicellular tumor spheroids |
![]() |
Targeted BCL2 inhibition effectively inhibits neuroblastoma tumour growth |
![]() |
Targeted BIRC5 silencing using YM155 causes cell death in neuroblastoma cells with low ABCB1 expression |
![]() |
Toxicity of upfront ¹³¹I-metaiodobenzylguanidine (¹³¹I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis |
![]() |
Treatment and outcome of neuroblastoma with intraspinal extension: A systematic review |
![]() |
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer |
![]() |
Upfront treatment of high-risk neuroblastoma with a combination of 131I-MIBG and topotecan |
![]() |
The use of equivalent radiation dose in the evaluation of late effects after childhood cancer treatment. |
![]() |
Validated assay for the simultaneous quantification of total vincristine and actinomycin-D concentrations in human EDTA plasma and of vincristine concentrations in human plasma ultrafiltrate by high-performance liquid chromatography coupled with tan |
![]() |
Valvular abnormalities detected by echocardiography in 5-year survivors of childhood cancer: a long-term follow-up study |
![]() |
Whole-Genome Sequencing Identifies Patient-Specific DNA Minimal Residual Disease Markers in Neuroblastoma |
![]() |
A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. |
![]() |